<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e>, an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> inherited disorder, is one of the most common forms of <z:hpo ids='HP_0002652'>skeletal dysplasia</z:hpo> resulting in disproportionate extreme shortness </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, two point mutations, both affecting nucleotide 1138 in the fibroblast growth factor receptor type 3 (FGFR3) gene, were found to be the cause of the disorder </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated DNA from 16 Swedish patients with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> for the presence of these mutations </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were found to be heterozygous for the G to A transition at nucleotide 1138 </plain></SENT>
<SENT sid="4" pm="."><plain>Our data thus support previous reports showing a striking genetic homogeneity, in that almost <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> patients have the FGFR3 G380R mutation at the protein level </plain></SENT>
</text></document>